Generation Bio Co. (GBIO) Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. Teva Pharmaceutical Industries Limited (TEVA) Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. Assembly Biosciences, Inc. (ASMB) Assembly Biosciences, Inc., a biopharmaceutical company, discovers […]
Read MoreBioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body’s natural healing process in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the […]
Read MoreCBIZ, Inc. (CBZ) CBIZ, Inc. provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. Intuitive Surgical, Inc. (ISRG) Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally […]
Read MoreAbsci Corporation (ABSI) is a biotechnology company that leverages artificial intelligence (AI) and synthetic biology to revolutionize drug discovery and development. Founded in 2011 by Sean McClain, the company is headquartered in Vancouver, Washington. Absci’s mission is to accelerate the development of innovative biologic drugs, which are crucial for treating a wide range of diseases, […]
Read MoreDyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its […]
Read MoreFusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. Its lead product candidates include FPI-2265 that is in Phase 2 clinical trial to treat prostate-specific membrane antigens; and FPI-1434 that is in Phase 1 clinical trial as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. […]
Read MoreAVITA Medical, Inc. operates as a regenerative medicine company in the United States, Australia, Japan, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo.
Read MoreCymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta for the treatments of autoimmune liver disease, primary biliary cholangitis (PBC).
Read MoreSummit Therapeutics Inc. (SMMT) Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily oncology therapies in the United States, and the United Kingdom. electroCore, Inc. (ECOR) electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. Cassava Sciences, Inc. […]
Read MoreGalectin Therapeutics Inc. (GALT) Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Stevanato Group S.p.A. (STVN) Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for biopharma and healthcare. Ionis Pharmaceuticals, Inc. […]
Read MoreAmneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment offers immediate and extended release oral solid, powder, liquid, sterile injectable, nasal spray, inhalation and respiratory, biosimilar, ophthalmic, film, transdermal patch, […]
Read MoreGalectin Therapeutics Inc. (GALT) Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Plus Therapeutics, Inc. (PSTV) Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. ARS Pharmaceuticals, […]
Read MoreArdelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. ARDX $3.8600 0.2600 % 7.2200 Ardelyx Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 7.22% Wk: 9.97% Mo: 15.92% Yrly: […]
Read MoreCymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. CBAY $11.6000 0.3300 % 2.9300 Cymabay Therapeutics Sector : Medical Industry : Medical – Generic Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 2.93% Wk: -4.65% Mo: 33.85% Yrly: 242.55% YTD: […]
Read MoreAVITA Medical, Inc. (RCEL) AVITA Medical, Inc. operates as a regenerative medicine company in the United States, Australia, Japan, and the United Kingdom. Marinus Pharmaceuticals, Inc. (MRNS) Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure disorders. Savara Inc. (SVRA) […]
Read More